DrLinda O'Neill

Dr O'Neill leads a programme of research focused on clinical trials of non-interventional medicinal products in cancer care, and trials methdology research.

Dr O'Neill's main research interest is cancer survivorship, in particular exercise oncology. She has extensive experience of leading and managing randomised controlled trials in exercise oncology. She is Principal Investigator for the HRB Investigator Led Clinical Trial Award, PRIME feasibility trial, wherein her team are establishing the feasibility of exercise and diet based rehabilitation post pancreatic resection. Prior to joining UCD, Dr O'Neill was Project Manager with the Trinity Exercise Oncology Research Group in the Discipline of Physiotherapy, School of Medicine, Trinity College Dublin (TCD). Dr O’Neill managed the Health Research Board funded 'Rehabilitation Strategies following Oesophago-gastric and Hepatopancreaticobiliary Cancer (RESTORE II) trial' and the Irish Cancer Society/ Health Research Board funded 'Preoperative Exercise to Improve Fitness in Patients Undergoing Complex Surgery for Cancer of the Lung or Oesophagus (PRE-HIIT) Trial'. She has over 40 publications in the field and her work has been presented widely at conferences both nationally and internationally, including at the prestigious European Surgical Association Meeting. 

Dr O’Neill is an experienced Trials Methodologist.  She is a Research Associate with the Health Research Board-Trials Methodology Research Network (HRB-TMRN), a member of the Trials Methodology Research Partnership (TMRP) Trial Conduct Group, and previously co-lead the TMRP Trial Conduct Working Group-Retention Topic Group. She has led a Study Within A Trial (SWAT) comparing by embedded randomised controlled trial patient co-designed participant information leaflets to standard participant information leaflets in terms of recruitment, retention, and trial understanding. Dr O’Neill has also supervised many undergraduate and post-graduate student projects in the field.